See also this year's filing and all EDGAR filings for this company.
PDF Report 0001401914_2023_Dare_Bioscience_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 2807885, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001401914, Dare Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,038,753 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 64,908 |
| 3 | remainder_Assets | 722,722 |
| 4 | LiabilitiesCurrent | 31,623,927 |
| 5 | LiabilitiesNoncurrent | 1,090,346 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,836,958 |
| 9 | ResearchAndDevelopmentExpense | 29,409,205 |
| 10 | remainder_Expenses | 100,000 |
| 11 | remainder_Revenues | 26,100 |
| 12 | remainder_NetIncome | 431,805 |
| 13 | remainder_ComprehensiveNetIncome | -860,102 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,826,383 |
| 1 | Liabilities | 32,714,273 |
| 2 | Expenses | 41,346,163 |
| 3 | Revenues | 26,100 |
| 4 | StockholdersEquity | 11,112,110 |
| 5 | NetIncome | -40,888,258 |
| 6 | ComprehensiveNetIncome | -41,318,309 |
| 7 | BaseVar | 59,602,413 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.447 |
| 9 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
